Scientech Research’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
Scientech Research's ABCL Position: Q2 2026 in Review
Scientech Research opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 15,404 shares worth $121K. The stake represents 0.1% of the portfolio and ranks #171 among its holdings. This is a return to the name: Scientech Research previously reported a position in ABCL as recently as Q4 2025.
Scientech Research first reported a position in ABCL in Q4 2025 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.
- Scientech Research held 15,404 shares of AbCellera Biologics worth $121K as of Q2 2026.
- AbCellera Biologics was a new Scientech Research position in Q2 2026.
- AbCellera Biologics made up 0.1% of Scientech Research's portfolio in Q2 2026, its #171 holding.
- Scientech Research first reported a position in AbCellera Biologics in Q4 2025 and has held it in 2 quarters since.
- 152 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.